Global Migraine Drugs Industry

New York, Oct. 14, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Migraine Drugs Industry" - https://www.reportlinker.com/p05817938/?utm_source=GNW
6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.8 Billion by the year 2025, Acute Treatment will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 16% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$162.6 Million to the region’s size and clout in the next 5 to 6 years. Over US$135.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Acute Treatment will reach a market size of US$237.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 23% over the next couple of years and add approximately US$1.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Allergan PLC; Amgen, Inc.; Biohaven Pharmaceutical Holding Company Ltd.; Eli Lilly and Company; GlaxoSmithKline PLC; Johnson & Johnson; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.


Read the full report: https://www.reportlinker.com/p05817938/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Migraine Drugs Competitor Market Share Scenario Worldwide
(in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Migraine Drugs Global Market Estimates and Forecasts
in US$ Thousand by Region/Country: 2018-2025
Table 2: Migraine Drugs Global Retrospective Market Scenario in
US$ Thousand by Region/Country: 2009-2017
Table 3: Migraine Drugs Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Acute Treatment (Treatment) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 5: Acute Treatment (Treatment) Historic Market Analysis
by Region/Country in US$ Thousand: 2009 to 2017
Table 6: Acute Treatment (Treatment) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Preventive Treatment (Treatment) Potential Growth
Markets Worldwide in US$ Thousand: 2018 to 2025
Table 8: Preventive Treatment (Treatment) Historic Market
Perspective by Region/Country in US$ Thousand: 2009 to 2017
Table 9: Preventive Treatment (Treatment) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Triptans (Therapeutic Class) Geographic Market Spread
Worldwide in US$ Thousand: 2018 to 2025
Table 11: Triptans (Therapeutic Class) Region Wise Breakdown of
Global Historic Demand in US$ Thousand: 2009 to 2017
Table 12: Triptans (Therapeutic Class) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Acetylcholine Inhibitors/Neurotoxins (Therapeutic
Class) World Market Estimates and Forecasts by Region/Country
in US$ Thousand: 2018 to 2025
Table 14: Acetylcholine Inhibitors/Neurotoxins (Therapeutic
Class) Market Historic Review by Region/Country in US$
Thousand: 2009 to 2017
Table 15: Acetylcholine Inhibitors/Neurotoxins (Therapeutic
Class) Market Share Breakdown by Region/Country: 2009 VS 2019
VS 2025
Table 16: Ergot Alkaloids (Therapeutic Class) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 17: Ergot Alkaloids (Therapeutic Class) Historic Market
Analysis by Region/Country in US$ Thousand: 2009 to 2017
Table 18: Ergot Alkaloids (Therapeutic Class) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 19: NSAIDs (Therapeutic Class) World Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018 to 2025
Table 20: NSAIDs (Therapeutic Class) Market Worldwide Historic
Review by Region/Country in US$ Thousand: 2009 to 2017
Table 21: NSAIDs (Therapeutic Class) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Other Therapeutic Classes (Therapeutic Class) Market
Opportunity Analysis Worldwide in US$ Thousand by
Region/Country: 2018 to 2025
Table 23: Other Therapeutic Classes (Therapeutic Class) Global
Historic Demand in US$ Thousand by Region/Country: 2009 to 2017
Table 24: Other Therapeutic Classes (Therapeutic Class) Market
Share Distribution in Percentage by Region/Country: 2009 VS
2019 VS 2025
Table 25: Oral (Route of Administration) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 26: Oral (Route of Administration) Historic Market
Analysis by Region/Country in US$ Thousand: 2009 to 2017
Table 27: Oral (Route of Administration) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 28: Injectables (Route of Administration) Potential
Growth Markets Worldwide in US$ Thousand: 2018 to 2025
Table 29: Injectables (Route of Administration) Historic Market
Perspective by Region/Country in US$ Thousand: 2009 to 2017
Table 30: Injectables (Route of Administration) Market Sales
Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 31: Other Route of Administrations (Route of
Administration) Geographic Market Spread Worldwide in US$
Thousand: 2018 to 2025
Table 32: Other Route of Administrations (Route of
Administration) Region Wise Breakdown of Global Historic Demand
in US$ Thousand: 2009 to 2017
Table 33: Other Route of Administrations (Route of
Administration) Market Share Distribution in Percentage by
Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Migraine Drugs Market Share (in %) by Company: 2019 & 2025
Table 34: United States Migraine Drugs Market Estimates and
Projections in US$ Thousand by Treatment: 2018 to 2025
Table 35: Migraine Drugs Market in the United States by
Treatment: A Historic Review in US$ Thousand for 2009-2017
Table 36: United States Migraine Drugs Market Share Breakdown
by Treatment: 2009 VS 2019 VS 2025
Table 37: United States Migraine Drugs Market Estimates and
Projections in US$ Thousand by Therapeutic Class: 2018 to 2025
Table 38: Migraine Drugs Market in the United States by
Therapeutic Class: A Historic Review in US$ Thousand for
2009-2017
Table 39: United States Migraine Drugs Market Share Breakdown
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 40: United States Migraine Drugs Market Estimates and
Projections in US$ Thousand by Route of Administration: 2018 to
2025
Table 41: Migraine Drugs Market in the United States by Route
of Administration: A Historic Review in US$ Thousand for
2009-2017
Table 42: United States Migraine Drugs Market Share Breakdown
by Route of Administration: 2009 VS 2019 VS 2025
CANADA
Table 43: Canadian Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Treatment: 2018 to 2025
Table 44: Canadian Migraine Drugs Historic Market Review by
Treatment in US$ Thousand: 2009-2017
Table 45: Migraine Drugs Market in Canada: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
Table 46: Canadian Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Therapeutic Class: 2018 to 2025
Table 47: Canadian Migraine Drugs Historic Market Review by
Therapeutic Class in US$ Thousand: 2009-2017
Table 48: Migraine Drugs Market in Canada: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 49: Canadian Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018 to
2025
Table 50: Canadian Migraine Drugs Historic Market Review by
Route of Administration in US$ Thousand: 2009-2017
Table 51: Migraine Drugs Market in Canada: Percentage Share
Breakdown of Sales by Route of Administration for 2009, 2019,
and 2025
JAPAN
Table 52: Japanese Market for Migraine Drugs: Annual Sales
Estimates and Projections in US$ Thousand by Treatment for the
Period 2018-2025
Table 53: Migraine Drugs Market in Japan: Historic Sales
Analysis in US$ Thousand by Treatment for the Period 2009-2017
Table 54: Japanese Migraine Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
Table 55: Japanese Market for Migraine Drugs: Annual Sales
Estimates and Projections in US$ Thousand by Therapeutic Class
for the Period 2018-2025
Table 56: Migraine Drugs Market in Japan: Historic Sales
Analysis in US$ Thousand by Therapeutic Class for the Period
2009-2017
Table 57: Japanese Migraine Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 58: Japanese Market for Migraine Drugs: Annual Sales
Estimates and Projections in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 59: Migraine Drugs Market in Japan: Historic Sales
Analysis in US$ Thousand by Route of Administration for the
Period 2009-2017
Table 60: Japanese Migraine Drugs Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
CHINA
Table 61: Chinese Migraine Drugs Market Growth Prospects in US$
Thousand by Treatment for the Period 2018-2025
Table 62: Migraine Drugs Historic Market Analysis in China in
US$ Thousand by Treatment: 2009-2017
Table 63: Chinese Migraine Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 64: Chinese Migraine Drugs Market Growth Prospects in US$
Thousand by Therapeutic Class for the Period 2018-2025
Table 65: Migraine Drugs Historic Market Analysis in China in
US$ Thousand by Therapeutic Class: 2009-2017
Table 66: Chinese Migraine Drugs Market by Therapeutic Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 67: Chinese Migraine Drugs Market Growth Prospects in US$
Thousand by Route of Administration for the Period 2018-2025
Table 68: Migraine Drugs Historic Market Analysis in China in
US$ Thousand by Route of Administration: 2009-2017
Table 69: Chinese Migraine Drugs Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
EUROPE
Market Facts & Figures
European Migraine Drugs Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Table 70: European Migraine Drugs Market Demand Scenario in US$
Thousand by Region/Country: 2018-2025
Table 71: Migraine Drugs Market in Europe: A Historic Market
Perspective in US$ Thousand by Region/Country for the Period
2009-2017
Table 72: European Migraine Drugs Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 73: European Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Treatment: 2018-2025
Table 74: Migraine Drugs Market in Europe in US$ Thousand by
Treatment: A Historic Review for the Period 2009-2017
Table 75: European Migraine Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
Table 76: European Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Therapeutic Class: 2018-2025
Table 77: Migraine Drugs Market in Europe in US$ Thousand by
Therapeutic Class: A Historic Review for the Period 2009-2017
Table 78: European Migraine Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 79: European Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018-2025
Table 80: Migraine Drugs Market in Europe in US$ Thousand by
Route of Administration: A Historic Review for the Period
2009-2017
Table 81: European Migraine Drugs Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
FRANCE
Table 82: Migraine Drugs Market in France by Treatment:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 83: French Migraine Drugs Historic Market Scenario in US$
Thousand by Treatment: 2009-2017
Table 84: French Migraine Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
Table 85: Migraine Drugs Market in France by Therapeutic Class:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 86: French Migraine Drugs Historic Market Scenario in US$
Thousand by Therapeutic Class: 2009-2017
Table 87: French Migraine Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 88: Migraine Drugs Market in France by Route of
Administration: Estimates and Projections in US$ Thousand for
the Period 2018-2025
Table 89: French Migraine Drugs Historic Market Scenario in US$
Thousand by Route of Administration: 2009-2017
Table 90: French Migraine Drugs Market Share Analysis by Route
of Administration: 2009 VS 2019 VS 2025
GERMANY
Table 91: Migraine Drugs Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Treatment for
the Period 2018-2025
Table 92: German Migraine Drugs Historic Market Analysis in US$
Thousand by Treatment: 2009-2017
Table 93: German Migraine Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
Table 94: Migraine Drugs Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Therapeutic
Class for the Period 2018-2025
Table 95: German Migraine Drugs Historic Market Analysis in US$
Thousand by Therapeutic Class: 2009-2017
Table 96: German Migraine Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 97: Migraine Drugs Market in Germany: Recent Past,
Current and Future Analysis in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 98: German Migraine Drugs Historic Market Analysis in US$
Thousand by Route of Administration: 2009-2017
Table 99: German Migraine Drugs Market Share Breakdown by Route
of Administration: 2009 VS 2019 VS 2025
ITALY
Table 100: Italian Migraine Drugs Market Growth Prospects in
US$ Thousand by Treatment for the Period 2018-2025
Table 101: Migraine Drugs Historic Market Analysis in Italy in
US$ Thousand by Treatment: 2009-2017
Table 102: Italian Migraine Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 103: Italian Migraine Drugs Market Growth Prospects in
US$ Thousand by Therapeutic Class for the Period 2018-2025
Table 104: Migraine Drugs Historic Market Analysis in Italy in
US$ Thousand by Therapeutic Class: 2009-2017
Table 105: Italian Migraine Drugs Market by Therapeutic Class:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 106: Italian Migraine Drugs Market Growth Prospects in
US$ Thousand by Route of Administration for the Period
2018-2025
Table 107: Migraine Drugs Historic Market Analysis in Italy in
US$ Thousand by Route of Administration: 2009-2017
Table 108: Italian Migraine Drugs Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
UNITED KINGDOM
Table 109: United Kingdom Market for Migraine Drugs: Annual
Sales Estimates and Projections in US$ Thousand by Treatment
for the Period 2018-2025
Table 110: Migraine Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Thousand by Treatment for the
Period 2009-2017
Table 111: United Kingdom Migraine Drugs Market Share Analysis
by Treatment: 2009 VS 2019 VS 2025
Table 112: United Kingdom Market for Migraine Drugs: Annual
Sales Estimates and Projections in US$ Thousand by Therapeutic
Class for the Period 2018-2025
Table 113: Migraine Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Thousand by Therapeutic Class
for the Period 2009-2017
Table 114: United Kingdom Migraine Drugs Market Share Analysis
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 115: United Kingdom Market for Migraine Drugs: Annual
Sales Estimates and Projections in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 116: Migraine Drugs Market in the United Kingdom:
Historic Sales Analysis in US$ Thousand by Route of
Administration for the Period 2009-2017
Table 117: United Kingdom Migraine Drugs Market Share Analysis
by Route of Administration: 2009 VS 2019 VS 2025
SPAIN
Table 118: Spanish Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Treatment: 2018 to 2025
Table 119: Spanish Migraine Drugs Historic Market Review by
Treatment in US$ Thousand: 2009-2017
Table 120: Migraine Drugs Market in Spain: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
Table 121: Spanish Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Therapeutic Class: 2018 to 2025
Table 122: Spanish Migraine Drugs Historic Market Review by
Therapeutic Class in US$ Thousand: 2009-2017
Table 123: Migraine Drugs Market in Spain: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 124: Spanish Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018 to
2025
Table 125: Spanish Migraine Drugs Historic Market Review by
Route of Administration in US$ Thousand: 2009-2017
Table 126: Migraine Drugs Market in Spain: Percentage Share
Breakdown of Sales by Route of Administration for 2009, 2019,
and 2025
RUSSIA
Table 127: Russian Migraine Drugs Market Estimates and
Projections in US$ Thousand by Treatment: 2018 to 2025
Table 128: Migraine Drugs Market in Russia by Treatment: A
Historic Review in US$ Thousand for 2009-2017
Table 129: Russian Migraine Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
Table 130: Russian Migraine Drugs Market Estimates and
Projections in US$ Thousand by Therapeutic Class: 2018 to 2025
Table 131: Migraine Drugs Market in Russia by Therapeutic
Class: A Historic Review in US$ Thousand for 2009-2017
Table 132: Russian Migraine Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 133: Russian Migraine Drugs Market Estimates and
Projections in US$ Thousand by Route of Administration: 2018 to
2025
Table 134: Migraine Drugs Market in Russia by Route of
Administration: A Historic Review in US$ Thousand for 2009-2017
Table 135: Russian Migraine Drugs Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 136: Rest of Europe Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Treatment: 2018-2025
Table 137: Migraine Drugs Market in Rest of Europe in US$
Thousand by Treatment: A Historic Review for the Period
2009-2017
Table 138: Rest of Europe Migraine Drugs Market Share Breakdown
by Treatment: 2009 VS 2019 VS 2025
Table 139: Rest of Europe Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Therapeutic Class: 2018-2025
Table 140: Migraine Drugs Market in Rest of Europe in US$
Thousand by Therapeutic Class: A Historic Review for the Period
2009-2017
Table 141: Rest of Europe Migraine Drugs Market Share Breakdown
by Therapeutic Class: 2009 VS 2019 VS 2025
Table 142: Rest of Europe Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018-2025
Table 143: Migraine Drugs Market in Rest of Europe in US$
Thousand by Route of Administration: A Historic Review for the
Period 2009-2017
Table 144: Rest of Europe Migraine Drugs Market Share Breakdown
by Route of Administration: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 145: Asia-Pacific Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 146: Migraine Drugs Market in Asia-Pacific: Historic
Market Analysis in US$ Thousand by Region/Country for the
Period 2009-2017
Table 147: Asia-Pacific Migraine Drugs Market Share Analysis by
Region/Country: 2009 VS 2019 VS 2025
Table 148: Migraine Drugs Market in Asia-Pacific by Treatment:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 149: Asia-Pacific Migraine Drugs Historic Market Scenario
in US$ Thousand by Treatment: 2009-2017
Table 150: Asia-Pacific Migraine Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
Table 151: Migraine Drugs Market in Asia-Pacific by Therapeutic
Class: Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 152: Asia-Pacific Migraine Drugs Historic Market Scenario
in US$ Thousand by Therapeutic Class: 2009-2017
Table 153: Asia-Pacific Migraine Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 154: Migraine Drugs Market in Asia-Pacific by Route of
Administration: Estimates and Projections in US$ Thousand for
the Period 2018-2025
Table 155: Asia-Pacific Migraine Drugs Historic Market Scenario
in US$ Thousand by Route of Administration: 2009-2017
Table 156: Asia-Pacific Migraine Drugs Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
AUSTRALIA
Table 157: Migraine Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Thousand by Treatment for
the Period 2018-2025
Table 158: Australian Migraine Drugs Historic Market Analysis
in US$ Thousand by Treatment: 2009-2017
Table 159: Australian Migraine Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
Table 160: Migraine Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Thousand by Therapeutic
Class for the Period 2018-2025
Table 161: Australian Migraine Drugs Historic Market Analysis
in US$ Thousand by Therapeutic Class: 2009-2017
Table 162: Australian Migraine Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 163: Migraine Drugs Market in Australia: Recent Past,
Current and Future Analysis in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 164: Australian Migraine Drugs Historic Market Analysis
in US$ Thousand by Route of Administration: 2009-2017
Table 165: Australian Migraine Drugs Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
INDIA
Table 166: Indian Migraine Drugs Market Estimates and Forecasts
in US$ Thousand by Treatment: 2018 to 2025
Table 167: Indian Migraine Drugs Historic Market Review by
Treatment in US$ Thousand: 2009-2017
Table 168: Migraine Drugs Market in India: Percentage Share
Breakdown of Sales by Treatment for 2009, 2019, and 2025
Table 169: Indian Migraine Drugs Market Estimates and Forecasts
in US$ Thousand by Therapeutic Class: 2018 to 2025
Table 170: Indian Migraine Drugs Historic Market Review by
Therapeutic Class in US$ Thousand: 2009-2017
Table 171: Migraine Drugs Market in India: Percentage Share
Breakdown of Sales by Therapeutic Class for 2009, 2019, and
2025
Table 172: Indian Migraine Drugs Market Estimates and Forecasts
in US$ Thousand by Route of Administration: 2018 to 2025
Table 173: Indian Migraine Drugs Historic Market Review by
Route of Administration in US$ Thousand: 2009-2017
Table 174: Migraine Drugs Market in India: Percentage Share
Breakdown of Sales by Route of Administration for 2009, 2019,
and 2025
SOUTH KOREA
Table 175: Migraine Drugs Market in South Korea: Recent Past,
Current and Future Analysis in US$ Thousand by Treatment for
the Period 2018-2025
Table 176: South Korean Migraine Drugs Historic Market Analysis
in US$ Thousand by Treatment: 2009-2017
Table 177: Migraine Drugs Market Share Distribution in South
Korea by Treatment: 2009 VS 2019 VS 2025
Table 178: Migraine Drugs Market in South Korea: Recent Past,
Current and Future Analysis in US$ Thousand by Therapeutic
Class for the Period 2018-2025
Table 179: South Korean Migraine Drugs Historic Market Analysis
in US$ Thousand by Therapeutic Class: 2009-2017
Table 180: Migraine Drugs Market Share Distribution in South
Korea by Therapeutic Class: 2009 VS 2019 VS 2025
Table 181: Migraine Drugs Market in South Korea: Recent Past,
Current and Future Analysis in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 182: South Korean Migraine Drugs Historic Market Analysis
in US$ Thousand by Route of Administration: 2009-2017
Table 183: Migraine Drugs Market Share Distribution in South
Korea by Route of Administration: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 184: Rest of Asia-Pacific Market for Migraine Drugs:
Annual Sales Estimates and Projections in US$ Thousand by
Treatment for the Period 2018-2025
Table 185: Migraine Drugs Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Thousand by Treatment for the
Period 2009-2017
Table 186: Rest of Asia-Pacific Migraine Drugs Market Share
Analysis by Treatment: 2009 VS 2019 VS 2025
Table 187: Rest of Asia-Pacific Market for Migraine Drugs:
Annual Sales Estimates and Projections in US$ Thousand by
Therapeutic Class for the Period 2018-2025
Table 188: Migraine Drugs Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Thousand by Therapeutic Class
for the Period 2009-2017
Table 189: Rest of Asia-Pacific Migraine Drugs Market Share
Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Table 190: Rest of Asia-Pacific Market for Migraine Drugs:
Annual Sales Estimates and Projections in US$ Thousand by Route
of Administration for the Period 2018-2025
Table 191: Migraine Drugs Market in Rest of Asia-Pacific:
Historic Sales Analysis in US$ Thousand by Route of
Administration for the Period 2009-2017
Table 192: Rest of Asia-Pacific Migraine Drugs Market Share
Analysis by Route of Administration: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 193: Latin American Migraine Drugs Market Trends by
Region/Country in US$ Thousand: 2018-2025
Table 194: Migraine Drugs Market in Latin America in US$
Thousand by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 195: Latin American Migraine Drugs Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 196: Latin American Migraine Drugs Market Growth
Prospects in US$ Thousand by Treatment for the Period 2018-2025
Table 197: Migraine Drugs Historic Market Analysis in Latin
America in US$ Thousand by Treatment: 2009-2017
Table 198: Latin American Migraine Drugs Market by Treatment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 199: Latin American Migraine Drugs Market Growth
Prospects in US$ Thousand by Therapeutic Class for the Period
2018-2025
Table 200: Migraine Drugs Historic Market Analysis in Latin
America in US$ Thousand by Therapeutic Class: 2009-2017
Table 201: Latin American Migraine Drugs Market by Therapeutic
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 202: Latin American Migraine Drugs Market Growth
Prospects in US$ Thousand by Route of Administration for the
Period 2018-2025
Table 203: Migraine Drugs Historic Market Analysis in Latin
America in US$ Thousand by Route of Administration: 2009-2017
Table 204: Latin American Migraine Drugs Market by Route of
Administration: Percentage Breakdown of Sales for 2009, 2019,
and 2025
ARGENTINA
Table 205: Argentinean Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Treatment: 2018-2025
Table 206: Migraine Drugs Market in Argentina in US$ Thousand
by Treatment: A Historic Review for the Period 2009-2017
Table 207: Argentinean Migraine Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
Table 208: Argentinean Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Therapeutic Class: 2018-2025
Table 209: Migraine Drugs Market in Argentina in US$ Thousand
by Therapeutic Class: A Historic Review for the Period
2009-2017
Table 210: Argentinean Migraine Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 211: Argentinean Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018-2025
Table 212: Migraine Drugs Market in Argentina in US$ Thousand
by Route of Administration: A Historic Review for the Period
2009-2017
Table 213: Argentinean Migraine Drugs Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
BRAZIL
Table 214: Migraine Drugs Market in Brazil by Treatment:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 215: Brazilian Migraine Drugs Historic Market Scenario in
US$ Thousand by Treatment: 2009-2017
Table 216: Brazilian Migraine Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
Table 217: Migraine Drugs Market in Brazil by Therapeutic
Class: Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 218: Brazilian Migraine Drugs Historic Market Scenario in
US$ Thousand by Therapeutic Class: 2009-2017
Table 219: Brazilian Migraine Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 220: Migraine Drugs Market in Brazil by Route of
Administration: Estimates and Projections in US$ Thousand for
the Period 2018-2025
Table 221: Brazilian Migraine Drugs Historic Market Scenario in
US$ Thousand by Route of Administration: 2009-2017
Table 222: Brazilian Migraine Drugs Market Share Analysis by
Route of Administration: 2009 VS 2019 VS 2025
MEXICO
Table 223: Migraine Drugs Market in Mexico: Recent Past,
Current and Future Analysis in US$ Thousand by Treatment for
the Period 2018-2025
Table 224: Mexican Migraine Drugs Historic Market Analysis in
US$ Thousand by Treatment: 2009-2017
Table 225: Mexican Migraine Drugs Market Share Breakdown by
Treatment: 2009 VS 2019 VS 2025
Table 226: Migraine Drugs Market in Mexico: Recent Past,
Current and Future Analysis in US$ Thousand by Therapeutic
Class for the Period 2018-2025
Table 227: Mexican Migraine Drugs Historic Market Analysis in
US$ Thousand by Therapeutic Class: 2009-2017
Table 228: Mexican Migraine Drugs Market Share Breakdown by
Therapeutic Class: 2009 VS 2019 VS 2025
Table 229: Migraine Drugs Market in Mexico: Recent Past,
Current and Future Analysis in US$ Thousand by Route of
Administration for the Period 2018-2025
Table 230: Mexican Migraine Drugs Historic Market Analysis in
US$ Thousand by Route of Administration: 2009-2017
Table 231: Mexican Migraine Drugs Market Share Breakdown by
Route of Administration: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 232: Rest of Latin America Migraine Drugs Market
Estimates and Projections in US$ Thousand by Treatment: 2018 to
2025
Table 233: Migraine Drugs Market in Rest of Latin America by
Treatment: A Historic Review in US$ Thousand for 2009-2017
Table 234: Rest of Latin America Migraine Drugs Market Share
Breakdown by Treatment: 2009 VS 2019 VS 2025
Table 235: Rest of Latin America Migraine Drugs Market
Estimates and Projections in US$ Thousand by Therapeutic Class:
2018 to 2025
Table 236: Migraine Drugs Market in Rest of Latin America by
Therapeutic Class: A Historic Review in US$ Thousand for
2009-2017
Table 237: Rest of Latin America Migraine Drugs Market Share
Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Table 238: Rest of Latin America Migraine Drugs Market
Estimates and Projections in US$ Thousand by Route of
Administration: 2018 to 2025
Table 239: Migraine Drugs Market in Rest of Latin America by
Route of Administration: A Historic Review in US$ Thousand for
2009-2017
Table 240: Rest of Latin America Migraine Drugs Market Share
Breakdown by Route of Administration: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 241: The Middle East Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 242: Migraine Drugs Market in the Middle East by
Region/Country in US$ Thousand: 2009-2017
Table 243: The Middle East Migraine Drugs Market Share
Breakdown by Region/Country: 2009, 2019, and 2025
Table 244: The Middle East Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Treatment: 2018 to 2025
Table 245: The Middle East Migraine Drugs Historic Market by
Treatment in US$ Thousand: 2009-2017
Table 246: Migraine Drugs Market in the Middle East: Percentage
Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
Table 247: The Middle East Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Therapeutic Class: 2018 to 2025
Table 248: The Middle East Migraine Drugs Historic Market by
Therapeutic Class in US$ Thousand: 2009-2017
Table 249: Migraine Drugs Market in the Middle East: Percentage
Share Breakdown of Sales by Therapeutic Class for 2009, 2019,
and 2025
Table 250: The Middle East Migraine Drugs Market Estimates and
Forecasts in US$ Thousand by Route of Administration: 2018 to
2025
Table 251: The Middle East Migraine Drugs Historic Market by
Route of Administration in US$ Thousand: 2009-2017
Table 252: Migraine Drugs Market in the Middle East: Percentage
Share Breakdown of Sales by Route of Administration for 2009,
2019, and 2025
IRAN
Table 253: Iranian Market for Migraine Drugs: Annual Sales
Estimates and Projections in US$ Thousand by Treatment for the
Period 2018-2025
Table 254: Migraine Drugs Market in Iran: Historic Sales
Analysis in US$ Thousand by Treatment for the Period 2009-2017
Table 255: Iranian Migraine Drugs Market Share Analysis by
Treatment: 2009 VS 2019 VS 2025
Table 256: Iranian Market for Migraine Drugs: Annual Sales
Estimates and Projections in US$ Thousand by Therapeutic Class
for the Period 2018-2025
Table 257: Migraine Drugs Market in Iran: Historic Sales
Analysis in US$ Thousand by Therapeutic Class for the Period
2009-2017
Table 258: Iranian Migraine Drugs Market Share Analysis by
Therapeutic Class: 2009 VS 2019 VS 2025

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05817938/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________